AGP Executive Report
Last update: 2 hours agoHealthcare Restructuring: CVS plans to split its $117 billion business, separating its pharmacy operations from its insurance arm. The move could reshape how the healthcare giant serves consumers, though questions remain about how independent the two businesses will be. Drug Oversight: HHS has cleared the sale of six unapproved peptides despite FDA guidance, putting renewed attention on how these products are regulated. Coverage Costs: With 2027 open enrollment underway, consumers are being urged to compare premiums, deductibles, provider networks and prescription coverage, and check eligibility for financial assistance. Smart Hospitals: Sunway Medical Centre retained Malaysia’s top smart-hospital ranking and rose to 226th globally, citing digital tools to improve patient safety and hospital efficiency. Diabetes Research: Sparrow Pharmaceuticals is adding about 80 people to its Phase 2b trial of clofutriben, testing whether the investigational treatment benefits patients with difficult-to-control type 2 diabetes across a broader range of cortisol levels. Nutrition Supply: Univar Solutions expanded its North American distribution deal with Roquette to include pea protein and soluble fibre, targeting fortified foods and sports nutrition.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
